The PI3K Pathway in Human Disease

Clicks: 315
ID: 119730
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #30 of 72 articles by views in Cell

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Phosphoinositide 3-kinase (PI3K) activity is stimulated by diverse oncogenes and growth factor receptors, and elevated PI3K signaling is considered a hallmark of cancer. Many PI3K pathway-targeted therapies have been tested in oncology trials, resulting in regulatory approval of one isoform-selectiv …
Reference Key
da2017cellthe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Fruman DA;Chiu H;Hopkins BD;Bagrodia S;Cantley LC;Abraham RT;;
Journal Cell
Year 2017
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/28802037
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review animals humans pubmed abstract nih national institutes of health national library of medicine signal transduction* neoplasms / drug therapy neoplasms / pathology neoplasms / metabolism pmid:28802037 pmc5726441 doi:10.1016/j.cell.2017.07.029 david a fruman honyin chiu robert t abraham cell physiological phenomena immune system / metabolism phosphatidylinositol 3-kinases / metabolism*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.